Professor Bo Angelin
Disclosure details
Consulting for Albireo and AstraZeneca, grant support from Amgen, AstraZeneca and Albireo.Senior Professor of Clinical Metabolic Research at Karolinska Institutet; Head of the Department of Endocrinology, Metabolism & Diabetes at Karolinska University Hospital; Director of the KI/AZ Integrated Cardiometabolic Center (ICMC), Sweden
